PI3K inhibitors
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PI3K inhibitors, covering 2024-09-26 to 2025-08-12. Get the full timeline:
Most recent: Clinical Trial Update: PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas [Phase 2]